Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.

Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, Lee BY.

Clin Microbiol Infect. 2017 Jan;23(1):48.e9-48.e16. doi: 10.1016/j.cmi.2016.09.003. Epub 2016 Sep 15.

2.

Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA).

Roth VR, Longpre T, Coyle D, Suh KN, Taljaard M, Muldoon KA, Ramotar K, Forster A.

PLoS One. 2016 Jul 27;11(7):e0159667. doi: 10.1371/journal.pone.0159667. eCollection 2016.

3.

Impact of different diagnostic technologies for MRSA admission screening in hospitals - a decision tree analysis.

Hübner C, Hübner NO, Wegner C, Flessa S.

Antimicrob Resist Infect Control. 2015 Dec 3;4:50. doi: 10.1186/s13756-015-0093-0. eCollection 2015.

4.

Reply to O'Riordan et al.

McKinnell JA, Bartsch SM, Lee BY, Huang SS, Miller LG.

Infect Control Hosp Epidemiol. 2015 Jul;36(7):857-8. doi: 10.1017/ice.2015.112. No abstract available.

5.

Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers.

McKinnell JA, Bartsch SM, Lee BY, Huang SS, Miller LG.

Infect Control Hosp Epidemiol. 2015 Jan;36(1):2-13. doi: 10.1017/ice.2014.1.

6.

A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission.

McKinnell JA, Miller LG, Eells SJ, Cui E, Huang SS.

Infect Control Hosp Epidemiol. 2013 Oct;34(10):1077-86. doi: 10.1086/673157. Epub 2013 Aug 19. Review.

7.

Tannic acid inhibits Staphylococcus aureus surface colonization in an IsaA-dependent manner.

Payne DE, Martin NR, Parzych KR, Rickard AH, Underwood A, Boles BR.

Infect Immun. 2013 Feb;81(2):496-504. doi: 10.1128/IAI.00877-12. Epub 2012 Dec 3.

8.

Prevention of influenza in healthy children.

Lee BY, Shah M.

Expert Rev Anti Infect Ther. 2012 Oct;10(10):1139-52. doi: 10.1586/eri.12.106. Review.

9.

Simulation shows hospitals that cooperate on infection control obtain better results than hospitals acting alone.

Lee BY, Bartsch SM, Wong KF, Yilmaz SL, Avery TR, Singh A, Song Y, Kim DS, Brown ST, Potter MA, Platt R, Huang SS.

Health Aff (Millwood). 2012 Oct;31(10):2295-303. doi: 10.1377/hlthaff.2011.0992. Erratum in: Health Aff (Millwood). 2012 Oct;31(10):2831.

10.

The potential economic value of screening hospital admissions for Clostridium difficile.

Bartsch SM, Curry SR, Harrison LH, Lee BY.

Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3163-71. doi: 10.1007/s10096-012-1681-z. Epub 2012 Jun 30.

12.

The potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients.

Song Y, Tai JH, Bartsch SM, Zimmerman RK, Muder RR, Lee BY.

Vaccine. 2012 May 21;30(24):3675-82. doi: 10.1016/j.vaccine.2012.03.031. Epub 2012 Mar 29.

13.

Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger.

Lee BY, Assi TM, Rajgopal J, Norman BA, Chen SI, Brown ST, Slayton RB, Kone S, Kenea H, Welling JS, Connor DL, Wateska AR, Jana A, Wiringa AE, Van Panhuis WG, Burke DS.

Am J Public Health. 2012 Feb;102(2):269-76. doi: 10.2105/AJPH.2011.300218. Epub 2011 Nov 28.

14.

The economic value of screening haemodialysis patients for methicillin-resistant Staphylococcus aureus in the USA.

Lee BY, Song Y, McGlone SM, Bailey RR, Feura JM, Tai JH, Lewis GJ, Wiringa AE, Smith KJ, Muder RR, Harrison LH, Piraino B.

Clin Microbiol Infect. 2011 Nov;17(11):1717-26. doi: 10.1111/j.1469-0691.2011.03525.x. Epub 2011 May 20.

15.

Economic value of Acinetobacter baumannii screening in the intensive care unit.

Lee BY, McGlone SM, Doi Y, Bailey RR, Harrison LH.

Clin Microbiol Infect. 2011 Nov;17(11):1691-7. doi: 10.1111/j.1469-0691.2011.03491.x. Epub 2011 Apr 4.

16.

The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus.

Lee BY, Wiringa AE, Bailey RR, Goyal V, Tsui B, Lewis GJ, Muder RR, Harrison LH.

Infect Control Hosp Epidemiol. 2010 Nov;31(11):1130-8. doi: 10.1086/656591. Erratum in: Infect Control Hosp Epidemiol. 2011 Jan;32(1):99. Harrison, Lee M [corrected to Harrison, Lee H].

17.

Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA.

Wassenberg MW, de Wit GA, van Hout BA, Bonten MJ.

PLoS One. 2010 Jul 16;5(7):e11562. doi: 10.1371/journal.pone.0011562.

Supplemental Content

Support Center